Table 5.
Acethylcholinesterase activities of the study population diagnosed with different psychiatric disorders. The p-values for each parameter were obtained by factorial ANOVA, and p < 0.05 was considered statistically significant.
Psychiatric Disorders | Acethylcholinesterase Activity Values | |||
---|---|---|---|---|
Specific Activity, mU/μLHb (Mean ± SD) |
Activity, mE/min (Mean ± SD) | % Activity (Mean ± SD) | % Inhibition (Mean ± SD) |
|
Depression disorder | ||||
Exposed | 436.49 ± 85.66 | 181.85 ± 22.85 | 77.94 ± 9.70 | 22.06 ± 9.71 |
Nonexposed | 481.31 ± 117.60 | 208.93 ± 33.71 | 89.45 ± 14.32 | 10.55 ± 14.32 |
p | 0.377 | 0.057 | 0.057 | 0.057 |
Major depression with suicidal risk | ||||
Exposed | 414.34 ± 92.75 | 174.89 ± 32.33 | 74.99 ± 13.74 | 25.01 ± 13.73 |
Nonexposed | 555.86 ± 55.25 | 228.43 ± 7.27 | 97.73 ± 3.08 | 2.27 ± 3.09 |
p | 0.000 | 0.000 | 0.000 | 0.000 |
Generalized anxiety | ||||
Exposed | 388.62 ± 90.04 | 177.48 ± 39.87 | 76.08 ± 16.94 | 23.91 ± 16.94 |
Nonexposed | 553.44 ± 72.42 | 228.11 ± 7.34 | 97.60 ± 3.12 | 2.340 ± 3.12 |
p | 0.000 | 0.000 | 0.000 | 0.000 |
Depression and generalized anxiety | ||||
Exposed | 421.66 ± 106.27 | 178.23 ± 48.70 | 76.40 ± 20.69 | 23.59 ± 20.69 |
Nonexposed | 566.99 ± 78.36 | 225.71 ± 8.20 | 96.58 ± 3.49 | 3.42 ± 3.49 |
p | 0.003 | 0.000 | 0.000 | 0.000 |
Without a psychiatric diagnosis | ||||
Exposed | 440.25 ± 108.81 | 181.96 ± 42.73 | 76.54 ± 15.93 | 22.01 ± 18.15 |
Nonexposed | 539.75 ± 63.44 | 229.28 ± 7.65 | 98.09 ± 3.25 | 1.91 ± 3.25 |
p | 0.000 | 0.000 | 0.000 | 0.000 |